Archive

The Lenacapavir PrEP Rollout offers six-month HIV protection, but aid cuts and clinic access gaps raise concerns for high-risk groups.

Employer health insurance costs may rise in 2027 as US firms shift higher premiums, deductibles and drug expenses onto staff.

Find out how DHMS AI prompts drive better health outcomes for Discovery Health Medical Scheme members through personalised guidance.

The Bonitas tender dispute raises governance concerns as Medscheme challenges tenders, trustee links and member migration problems.

South Africa must address critical child stunting risks to meet its 2030 health targets, as experts warn of municipal service failures.

Uncover the potential of mRNA vaccines that show promise for personalized cancer treatments that target tumor cells effectively.

Learn how reliance on imported medicines threatens South Africa’s jobs and the industry’s pharmaceutical security.

Malaria cases surge despite efforts to eliminate the disease. Discover the impact of weather conditions on this worrying trend.

The lenacapavir HIV Prevention Injection rollout begins in SA, but activists warn that limited supply from Gilead could blunt the impact.

Daraxonrasib Pancreatic Cancer Pill nearly doubled survival in metastatic PDAC, beating second-line chemo with fewer discontinuations.

Medical scheme financial pressure intensifies as healthcare costs, an ageing population, and a R11.64bn operating deficit squeeze the sector.